The 4-DSD: A New Tool to Assess Delirium Superimposed on Moderate to Severe Dementia
Overview
Authors
Affiliations
Objectives: The purpose of this study was to create, standardize, and validate a new instrument, named 4-DSD, and determine its diagnostic accuracy in the diagnosis of delirium in subjects with moderate to severe dementia.
Design: Multicenter cross-sectional observational study.
Setting And Participants: Older patients consecutively admitted to acute and rehabilitation hospital wards.
Measures: The DSM-5 was used as the reference standard delirium assessment. The presence and severity of dementia was defined using the AD8 and the Global Deterioration Scale (GDS). The 4-DSD is a 4-item tool that ranges from 0 to 12. Item 1 measures alertness, item 2 altered function, item 3 attention, and item 4 acute change or fluctuation in mental status.
Results: A total of 134 patients were included in the study. Most of the patients were enrolled in acute hospital wards (60%), with 40% in rehabilitation settings. A minority of the patients were categorized with moderate dementia, with a GDS score of 5 (4%). Most of the patients were in the moderate-severe stage with a GDS score ≤6 (77%); 19% were classed as severe, with a GDS score of 7. A 4-DSD cutoff score ≥5 had a sensitivity of 80% and specificity of 80% with a positive predictive value (PPV) of 67% and a negative predictive value (NPV) of 89%. In the subgroup with moderate-severe dementia (n = 108), the sensitivity and the specificity were 79% and 82%, respectively, with a PPV and NPV of 62% and 92%. In the subgroup with severe dementia (n = 26) the sensitivity was 82% and the specificity 56% with a PPV of 78% and a NPV of 63%.
Conclusions And Implications: The availability of a specific tool to detect delirium in patients with moderate-severe dementia has important clinical and research implications, allowing all health care providers to improve their ability to identify it.
Delirium in nursing home residents: is there a role of antidepressants? A cross sectional study.
Fedecostante M, Balietti P, Di Santo S, Zambon A, Marengoni A, Morandi A BMC Geriatr. 2024; 24(1):767.
PMID: 39289644 PMC: 11409737. DOI: 10.1186/s12877-024-05360-z.
Huang C, Wu B, Chen H, Tao H, Wei Z, Su L BMC Nurs. 2024; 23(1):464.
PMID: 38977984 PMC: 11229275. DOI: 10.1186/s12912-024-02121-6.
Recognition of Delirium Superimposed on Dementia: Is There an Ideal Tool?.
Shrestha P, Fick D Geriatrics (Basel). 2023; 8(1).
PMID: 36826364 PMC: 9957529. DOI: 10.3390/geriatrics8010022.
Advancing the Care of Delirium and Comorbid Dementia.
Morandi A, Wittmann M, Bilotta F, Bellelli G Geriatrics (Basel). 2022; 7(6).
PMID: 36547268 PMC: 9778046. DOI: 10.3390/geriatrics7060132.
MacLullich A, Hosie A, Tieges Z, Davis D Age Ageing. 2022; 51(11).
PMID: 36441120 PMC: 9704028. DOI: 10.1093/ageing/afac271.